Scrambler therapy for established chemotherapy-induced neuropathy: A randomized phase II trial.

10016Background: Pilot data support that Scrambler therapy may benefit patients with Chemotherapy-induced peripheral neuropathy (CIPN). Methods: Patients with CIPN for at least 3 months were eligib...